No pricks: Oral TB drug for under 5 gets nod | India News – Times of India
MUMBAI: In the battle against drug-resistant tuberculosis (TB), young children have faced a particularly challenging hurdle: the painful injectables in treatment regimens. These medications, notorious for their severe side effects, added an extra layer of distress to an already daunting ordeal for infants and children. Now, with approval of Delamanid for children under 5 in…